Page 2 - நீரிழிவு கால் புண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீரிழிவு கால் புண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீரிழிவு கால் புண் Today - Breaking & Trending Today

Diabetic Foot Ulcer Treatment Market Expected to Witness a High Jump as the Market is Projected to Grow with a CAGR of 17.0% During the Study Period (2018-2030)


leading cause of non-traumatic lower extremity amputations in the United States, and approximately
14-24% of patients with diabetes who develop a foot ulcer will require an
amputation. Foot ulceration precedes
85% of diabetes-related amputations.
The gold standard for Diabetic Foot Ulcer treatment includes debridement of the wound, management of any infection, revascularization procedures when indicated, and off-loading of the ulcer.
Currently, the market is mainly dominated by
off-label generic drugs such as analgesics and anti-infectives,
around 78% of the current market is captured by these two classes of drugs. 
There is only one drug,
Regranex (Becaplermin), which the FDA has approved.
Regranex gel uses a Platelet-derived growth factor (PDGF) for the Diabetic Neuropathic Ulcer treatment formulated to act as a first-line treatment following effective ulcer care. The US FDA had approved the biologics license application of Beca ....

United States , United Kingdom , Shruti Thakur , Amniox Tissuetech , Donaperminogene Seltoplasmid , Regranex Becaplermin , Ticeba Gmb , Prnewswire Delveinsight , Helixmith Co Ltd , Biotherapy Services , Market Companies , Amedex Inc , Oneness Biotech Co Ltd , Market Research , American Podiatric Medical Association , Gmbh Co , Diabetic Gastroparesis Market Research , Microbion Corporation , Delveinsight Business Research , Foot Ulcer , Diabetic Foot Ulcer , Diabetic Neuropathic Ulcer , Ticeba Gmbh , Lakewood Amedex Inc , Aurealis Therapeutics , Amniox Medical ,

Global Diabetic Foot Ulcer Market to 2030 - Insights, Epidemiology, and Forecasts

The "Diabetic Foot Ulcer - Market Insights, Epidemiology, and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. ....

Diabetic Ulcers , Diabetic Foot Ulcer , நீரிழிவு புண்கள் , நீரிழிவு கால் புண் ,

Diabetic Foot Ulcer (DFU) Market Growth Opportunities 2021-2027, Business Investment with Leading Companies

Spectral MD Initiates Multi-Center Clinical Study for Diabetic Foot Ulcer


Share:
DALLAS, Dec. 18, 2020 /PRNewswire/  Spectral MD announced today the start of an IRB-approved multi-center study to support the development of its Diabetic Foot Ulcer (DFU) application for the DeepView Wound Imaging System. The patented DeepView Wound Imaging System combines multi-spectral imaging and Artificial Intelligence (AI) to provide clinicians with an immediate healing assessment for DFU, which enables clinicians to provide a more accurate and timely diagnosis for therapeutic intervention. Building upon promising results from a 2019 proof-of-concept study, Spectral MD will bolster its existing clinical database of DFU images and physiologic information to train and improve the diagnostic accuracy of the DeepView AI algorithm. ....

United States , Jeffrey Carter , Jeffrey Thatcher , Terry Treadwell , Association For The Advancement Of Wound Care , Diabetic Foot Ulcer , Deepview Wound Imaging , Deepview Wound Imaging System , Artificial Intelligence , Wound Care , Medical Director , Advanced Wound Care , Baptist Medical Center , Principal Investigator , Chief Medical Consultant , Chief Scientist , Wound Imaging , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி கார்ட்டர் , ஜெஃப்ரி தாட்சர் , டெர்ரி ட்ரெட்வெல் , நீரிழிவு கால் புண் , செயற்கை உளவுத்துறை , காயம் பராமரிப்பு , மருத்துவ இயக்குனர் , ஞானஸ்நானம் மருத்துவ மையம் ,